+Open data
-Basic information
Entry | Database: PDB chemical components / ID: RT2 | ||||
---|---|---|---|---|---|
Name | Name: Wikipedia | Wikipedia - Tofogliflozin: Tofogliflozin (INN,: 88 USAN, codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi. It is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney... | Comment | inhibitor*YM | |
-Chemical information
Composition | Formula: C22H26O6 / Number of atoms: 54 / Formula weight: 386.438 / Formal charge: 0 | ||||
---|---|---|---|---|---|
Others | Type: non-polymer / PDB classification: HETAIN / Three letter code: RT2 / Ideal coordinates details: Corina / Model coordinates PDB-ID: 7APH | ||||
History |
| ||||
External links | UniChem / PubChem / ChemSpider / Wikipedia search / Google search |
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Details
-SMILES
CACTVS 3.385 | OpenEye OEToolkits 2.0.7 | |
---|
-SMILES CANONICAL
CACTVS 3.385 | OpenEye OEToolkits 2.0.7 | |
---|
-InChI
InChI 1.03 |
---|
-InChIKey
InChI 1.03 |
---|
-PDB entries
Showing all 1 items
PDB-7aph:
Structure of SARS-CoV-2 Main Protease bound to Tofogliflozin.